- Posterior pelvic exenteration, a crucial component in the surgeon’s toolbox for optimizing surgical cytoreduction for advanced ovarian cancer
-
Moukarzel LA, Chi DS
- KMID: 2536995
- J Gynecol Oncol.
- 2022 May;33(3):e41.
- doi: 10.3802/jgo.2022.33.e41
-
- CITED
-
- Close
- SHARE
-
- Close
- Why was GOG-0213 a negative trial?
-
Ehmann S, Zivanovic O, Chi DS
- KMID: 2526288
- J Gynecol Oncol.
- 2021 Jan;32(1):e19.
- doi: 10.3802/jgo.2021.32.e19
-
- CITED
-
- Close
- SHARE
-
- Close
- Rectosigmoid resection by gynecologic oncologists versus colorectal surgeons: as long as it catches the mouse, does the color of the cat matter?
-
Chang SJ, Fotopoulou C, Bristow RE, Chi DS, Cliby WA
- KMID: 2526406
- J Gynecol Oncol.
- 2021 May;32(3):e51.
- doi: 10.3802/jgo.2021.32.e51
-
- CITED
-
- Close
- SHARE
-
- Close
- Maximal cytoreductive effort in epithelial ovarian cancer surgery
-
Shih KK, Chi DS
- KMID: 2009574
- J Gynecol Oncol.
- 2010 Jun;21(2):75-80.
- doi: 10.3802/jgo.2010.21.2.75
The surgical management of advanced epithelial ovarian cancer involves cytoreduction, or removal of grossly-evident tumor. Residual disease after surgical cytoreduction of ovarian cancer has been shown to be strongly associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of aggressive surgical cytoreduction in advanced ovarian cancer
-
Chang SJ, Bristow RE, Chi DS, Cliby WA
- KMID: 2345925
- J Gynecol Oncol.
- 2015 Oct;26(4):336-342.
- doi: 10.3802/jgo.2015.26.4.336
Ovarian cancer is the eighth most frequent cancer in women and is the most lethal gynecologic malignancy worldwide. The majority of ovarian cancer patients are newly diagnosed presenting with advanced-stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery
-
Mironov O, Sala E, Mironov S, Pannu H, Chi DS, Hricak H
- KMID: 2173628
- J Gynecol Oncol.
- 2011 Dec;22(4):260-268.
- doi: 10.3802/jgo.2011.22.4.260
OBJECTIVE: To determine which computed tomography (CT) imaging features predict pleural malignancy in patients with advanced epithelial ovarian carcinoma (EOC) using video-assisted thoracic surgery (VATS), pathology, and cytology findings as... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
-
Liu YL, Filippova OT, Zhou Q, Iasonos A, Chi DS, Zivanovic O, Sonoda Y, Gardner GJ, Broach VA, O'Cearbhaill RE, Konner JA, Aghajanian C, Long Roche K, Tew WP
- KMID: 2465191
- J Gynecol Oncol.
- 2020 Jan;31(1):e17.
- doi: 10.3802/jgo.2020.31.e17
OBJECTIVE: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) confers similar outcomes as primary debulking surgery and chemotherapy. Little is known about patients who receive NACT but do not... -
- CITED
-
- Close
- SHARE
-
- Close
